Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 32% ± 15% | |
peripheral blood | 8 studies | 21% ± 5% | |
kidney | 8 studies | 25% ± 5% | |
intestine | 7 studies | 25% ± 11% | |
brain | 7 studies | 23% ± 7% | |
eye | 6 studies | 30% ± 15% | |
uterus | 4 studies | 36% ± 18% | |
breast | 4 studies | 22% ± 2% | |
pancreas | 3 studies | 47% ± 10% | |
placenta | 3 studies | 31% ± 4% | |
skin | 3 studies | 21% ± 4% | |
prostate | 3 studies | 23% ± 7% | |
liver | 3 studies | 31% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 3943.27 | 2642 / 2642 | 100% | 124.18 | 705 / 705 |
esophagus | 100% | 3237.38 | 1445 / 1445 | 100% | 88.00 | 183 / 183 |
lung | 100% | 3805.06 | 578 / 578 | 100% | 131.26 | 1155 / 1155 |
ovary | 100% | 2825.28 | 180 / 180 | 100% | 89.61 | 430 / 430 |
breast | 100% | 3503.51 | 459 / 459 | 100% | 128.69 | 1116 / 1118 |
bladder | 100% | 3220.81 | 21 / 21 | 100% | 112.50 | 503 / 504 |
prostate | 100% | 3606.72 | 245 / 245 | 100% | 125.98 | 501 / 502 |
stomach | 100% | 2537.62 | 359 / 359 | 100% | 94.99 | 285 / 286 |
uterus | 100% | 3076.92 | 170 / 170 | 100% | 122.13 | 457 / 459 |
thymus | 100% | 3489.83 | 653 / 653 | 100% | 131.98 | 602 / 605 |
intestine | 100% | 3346.31 | 966 / 966 | 99% | 106.42 | 523 / 527 |
kidney | 100% | 4286.74 | 89 / 89 | 99% | 103.41 | 890 / 901 |
adrenal gland | 100% | 3593.51 | 258 / 258 | 98% | 108.42 | 225 / 230 |
liver | 100% | 1672.81 | 226 / 226 | 97% | 57.64 | 395 / 406 |
pancreas | 98% | 1250.23 | 321 / 328 | 99% | 104.42 | 176 / 178 |
skin | 100% | 3468.82 | 1808 / 1809 | 95% | 84.88 | 447 / 472 |
adipose | 100% | 3665.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3684.65 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 96.36 | 29 / 29 |
spleen | 100% | 3000.50 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 94.24 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 76.46 | 1 / 1 |
heart | 99% | 2222.71 | 853 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 1880.18 | 795 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 47.44 | 69 / 80 |
peripheral blood | 74% | 2549.84 | 692 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001778 | Biological process | plasma membrane repair |
GO_0051469 | Biological process | vesicle fusion with vacuole |
GO_0039702 | Biological process | viral budding via host ESCRT complex |
GO_0036258 | Biological process | multivesicular body assembly |
GO_0046755 | Biological process | viral budding |
GO_0061763 | Biological process | multivesicular body-lysosome fusion |
GO_1901673 | Biological process | regulation of mitotic spindle assembly |
GO_0001919 | Biological process | regulation of receptor recycling |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0061952 | Biological process | midbody abscission |
GO_0090148 | Biological process | membrane fission |
GO_0006997 | Biological process | nucleus organization |
GO_0030218 | Biological process | erythrocyte differentiation |
GO_0010824 | Biological process | regulation of centrosome duplication |
GO_0032511 | Biological process | late endosome to vacuole transport via multivesicular body sorting pathway |
GO_0046761 | Biological process | viral budding from plasma membrane |
GO_1902774 | Biological process | late endosome to lysosome transport |
GO_0071985 | Biological process | multivesicular body sorting pathway |
GO_0006900 | Biological process | vesicle budding from membrane |
GO_1904903 | Biological process | ESCRT III complex disassembly |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0015031 | Biological process | protein transport |
GO_0006914 | Biological process | autophagy |
GO_0071225 | Biological process | cellular response to muramyl dipeptide |
GO_0097352 | Biological process | autophagosome maturation |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0031468 | Biological process | nuclear membrane reassembly |
GO_0000815 | Cellular component | ESCRT III complex |
GO_0030496 | Cellular component | midbody |
GO_0005643 | Cellular component | nuclear pore |
GO_0005886 | Cellular component | plasma membrane |
GO_0000776 | Cellular component | kinetochore |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005828 | Cellular component | kinetochore microtubule |
GO_0005829 | Cellular component | cytosol |
GO_0005771 | Cellular component | multivesicular body |
GO_1904930 | Cellular component | amphisome membrane |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0045296 | Molecular function | cadherin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CHMP5 |
Protein name | Charged multivesicular body protein 5 (Chromatin-modifying protein 5) (SNF7 domain-containing protein 2) (Vacuolar protein sorting-associated protein 60) (Vps60) (hVps60) |
Synonyms | HSPC177 PNAS-114 C9orf83 CGI-34 PNAS-2 SNF7DC2 |
Description | FUNCTION: Probable peripherally associated component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses) . ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Involved in HIV-1 p6- and p9-dependent virus release . . |
Accessions | Q9NZZ3 ENST00000419016.6 [Q9NZZ3-2] ENST00000223500.9 [Q9NZZ3-1] |